Provided by Tiger Trade Technology Pte. Ltd.

Protagonist Therapeutics

91.07
+0.82000.91%
Volume:115.12K
Turnover:10.53M
Market Cap:5.69B
PE:126.45
High:92.75
Open:89.73
Low:88.43
Close:90.25
52wk High:93.25
52wk Low:33.70
Shares:62.52M
Float Shares:43.15M
Volume Ratio:0.99
T/O Rate:0.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7202
EPS(LYR):4.47
ROE:7.80%
ROA:1.82%
PB:8.82
PE(LYR):20.37

Loading ...

Protagonist Therapeutics Inc : Bmo Raises Target Price to $112 From $72

THOMSON REUTERS
·
Oct 13

U.S. Stocks to Watch: MP Materials, Nvidia, AMD, Tesla, Alibaba, Fastenal, and More

Dow Jones
·
Oct 13

Why Protagonist Therapeutics Stock Skyrocketed by Almost 30% Today

Motley Fool
·
Oct 11

Deals of the day-Mergers and acquisitions

Reuters
·
Oct 11

Sector Update: Health Care Stocks Decline Friday Afternoon

MT Newswires Live
·
Oct 11

Dow Jones Top Company Headlines at 1 PM ET: Johnson & Johnson in Talks to Buy Protagonist Therapeutics | Canada, ...

Dow Jones
·
Oct 11

M&A News: Protagonist Therapeutics Stock (PTGX) is Star of the Show on JNJ Bid Talk

TIPRANKS
·
Oct 11

Protagonist Therapeutics rises 34.1%

TIPRANKS
·
Oct 11

Protagonist Therapeutics Shares Extend Gains, Last up 34%

THOMSON REUTERS
·
Oct 11

Top Midday Stories: Trump Threatens 'Massive' Tariff Raise on China; Nvidia Chips Face Higher Scrutiny at China Customs

MT Newswires Live
·
Oct 10

BUZZ-Protagonist Therapeutics surges after media reports J&J in talks to buy co

Reuters
·
Oct 10

Protagonist Therapeutics resumes, up 28% after report of J&J takeover talks

TIPRANKS
·
Oct 10

Market Chatter: Johnson & Johnson in Talks to Acquire Protagonist Therapeutics

MT Newswires Live
·
Oct 10

Protagonist Therapeutics Shares Rise 9.4% After WSJ Reports Johnson & Johnson in Talks to Buy Co

THOMSON REUTERS
·
Oct 10

Protagonist Stock Surges on Johnson & Johnson Report -- WSJ

Dow Jones
·
Oct 10

Johnson & Johnson in Talks to Acquire Protagonist Therapeutics, WSJ Reports

MT Newswires Live
·
Oct 10

J&J in talks to buy Protagonist Therapeutics, WSJ reports

TIPRANKS
·
Oct 10

BRIEF-Johnson & Johnson In Talks To Buy Protagonist Therapeutics - WSJ

Reuters
·
Oct 10

Protagonist Therapeutics trading halted, volatility trading pause

TIPRANKS
·
Oct 10

Protagonist Therapeutics participates in a conference call with JPMorgan

TIPRANKS
·
Oct 10